To determine the clinical correlation between PD-L1 and METTL3 or IGF2BP3, IHC staining was performed to verify the protein expression of METTL3, IGF2BP3, and PD-L1 using a tissue microarray consisting of 140 breast cancer tissues. The gene discussed is IGF2BP3; the disease is breast carcinoma.